Skip to main content

Casper Marc N's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Aug 21, 2025

Accession no.
0000097745-25-000105
Filed
Aug 21, 2025
Trade date
Aug 19-20, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $248.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casper Marc NCIK 0001216055Director, Officer (Chairman & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2025Common StockMOption exerciseAcquired+201$253.99+$51,051.99115,374.62Direct
Aug 19, 2025Common StockSSaleDisposed−201$500.17−$100,534.17115,173.62Direct
Aug 20, 2025Common StockMOption exerciseAcquired+295$253.99+$74,927.05115,468.62Direct
Aug 20, 2025Common StockSSaleDisposed−200$500.00−$100,000115,268.62Direct
Aug 20, 2025Common StockSSaleDisposed−95$500.13−$47,512.35115,173.62Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 19, 2025Common StockMOption exerciseDisposed−201$0.00$035,049Direct
Aug 20, 2025Common StockMOption exerciseDisposed−295$0.00$034,754Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)